MedTrace Logo

Evaluation of the Patient's Risk Profile Using the Peri-implantitis Risk Diagram

NCT05618171 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 170

Last updated 2024-03-18

No results posted yet for this study

Summary

Various risk factors defined in the literature should be eliminated in order for the patient to be able to use implant-supported prostheses for a longer period of time. In the literature, such a diagram for peri-implant risk factors was first described by Heitz-Mayfield in 2020. The scheme that will determine the peri-implant risk diagram is called "Implant Disease Risk Assessment (IDRA)". This tool provides evaluation of various risk factors on a single diagram. In this study, peri-implant risk diagrams will be determined by calling the patients who have previously completed implant treatment in Kütahya University of Health Sciences Faculty of Dentistry Department of Periodontology, and the change in the risk profile assessment will be re-evaluated after the risk factors that can be eliminated are eliminated. In this study, it is aimed to predict the risk of inflammation and alveolar bone loss of the tissues around the implant that may occur in the future in patients who have undergone dental implant treatment, and to evaluate the risk profiles.

Conditions

  • Peri-Implantitis
  • Peri-implant Mucositis
  • Dental Implant Failed

Interventions

DIAGNOSTIC_TEST

Evaluation of the patient's pre- and post-treatment risk profile using the peri-implantitis risk diagram

By using "IDRA", a tool specially developed for patients who have had dental implants in our clinic, patients will be evaluated as "low-moderate-high" risk in terms of the risk of developing peri-implantitis, according to their initial status. Again, these patients will be re-evaluated 1 year after applying Phase I treatment using the "IDRA" tool. During this whole process, clinical and radiographic evaluations will be carried out simultaneously.

Sponsors & Collaborators

  • Berceste Guler

    lead OTHER

Principal Investigators

  • Berceste Güler · Kütahya Health Sciences University Faculty of Dentistry

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-12-01
Primary Completion
2021-09-05
Completion
2022-01-28

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05618171 on ClinicalTrials.gov